Nexalin Technology, Inc. (NXL) stock
NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.44−0.06 (-4.00%)
Close on Nov 18, 2026Market cap $31.73MP/E –Yield –
Nexalin Technology operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Nexalin Technology's operating cash flow for the twelve months ending Jun 30, 2026 was -$6.13M. For fiscal 2025 it was -$4.96M. The highest annual figure on record is -$1.08M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.96M | – |
| FY2024 | Dec 31, 2024 | -$3.94M | – |
| FY2023 | Dec 31, 2023 | -$3.84M | – |
| FY2022 | Dec 31, 2022 | -$2.22M | – |
| FY2021 | Dec 31, 2021 | -$1.08M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.80M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.71M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.15M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.47M | – |
| Q2 FY2025 | Jun 30, 2025 | -$917.17K | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.43M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.13M | – |
| Q3 FY2024 | Sep 30, 2024 | -$800.21K | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.25M | – |
| Q1 FY2024 | Mar 31, 2024 | -$763.29K | – |
| Q2 FY2023 | Jun 30, 2023 | -$815.61K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.31M | – |
| Q4 FY2022 | Dec 31, 2022 | -$906.46K | – |
| Q3 FY2022 | Sep 30, 2022 | -$943.70K | – |
| Q2 FY2022 | Jun 30, 2022 | -$162.27K | – |
| Q1 FY2022 | Mar 31, 2022 | -$203.27K | – |
| Q4 FY2021 | Dec 31, 2021 | -$409.09K | – |
See a number that looks wrong?